Boardroom Alpha
Boardroom Alpha
JPM · Current Report (Form 8-K) · Filed May 21, 2026

JPMorgan Chase & Co — Current Report (Form 8-K)

Form
8-K
Filed
May 21, 2026
Period
May 19, 2026
Ticker
JPM
Accession
0000019617-26-000228
Boardroom Alpha · Filing insights

Shareholders reelected all 11 directors, approved executive compensation and PwC audit; rejected governance proposals.

About JPMorgan Chase & Co
Market cap
$806.4B
1Y TSR
+13.5%
3Y TSR
+32.1%
Board grade
B
Sector
Financial Services
CEO
James Dimon
Last annual meeting: May 19, 2026 · View full JPMorgan Chase & Co profile →
jpm-20260519

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 19, 2026
JPMorgan Chase & Co.
(Exact name of registrant as specified in its charter)
Delaware1-580513-2624428
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(I.R.S. employer
identification no.)
270 Park Avenue,
New York,New York10017
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (212) 270-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stockJPMThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DDJPM PR DThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EEJPM PR CThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GGJPM PR JThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJJPM PR KThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LLJPM PR LThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MMJPM PR MThe New York Stock Exchange
Guarantee of Callable Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLC
JPM/32The New York Stock Exchange
Guarantee of Alerian MLP Index ETNs due January 28, 2044 of JPMorgan Chase Financial Company LLCAMJBNYSE Arca, Inc.
Guarantee of Inverse VIX Short-Term Futures ETNs due March 22, 2045 of JPMorgan Chase Financial Company LLCVYLDNYSE Arca, Inc.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) Registrant held its Annual Meeting of Shareholders on Tuesday, May 19, 2026; 2,284,422,677 shares were represented in person or by proxy, or 85.17% of the total shares outstanding.
(b) The results of the shareholder voting on the proposals presented were as follows:

MANAGEMENT PROPOSALS
Proposal 1 - Shareholders elected the 11 director nominees named in the Proxy Statement. All director nominees received at least 92.37% of the votes cast.
NameForAgainstAbstainBroker Non-Votes
Linda B. Bammann1,844,888,53979,675,1583,564,611356,294,369
Michele G. Buck1,900,015,21923,196,4054,916,684356,294,369
Stephen B. Burke1,777,524,386146,840,6903,763,232356,294,369
Alicia Boler Davis1,915,243,3598,999,6653,885,284356,294,369
James Dimon1,822,400,66698,992,8426,734,800356,294,369
Alex Gorsky1,898,772,48725,619,2973,736,524356,294,369
Mellody Hobson1,903,661,23620,811,2653,655,807356,294,369
Phebe N. Novakovic1,905,508,11318,825,8123,794,383356,294,369
Virginia M. Rometty1,840,528,70983,734,6323,864,967356,294,369
Brad D. Smith1,916,788,6317,317,5504,022,127356,294,369
Mark A. Weinberger1,896,355,12027,971,8993,801,289356,294,369
Proposal 2 - Shareholders approved the advisory resolution to approve executive compensation.
ForAgainstAbstainBroker Non-Votes
1,780,600,132139,352,4208,175,756356,294,369
92.35 %7.23 %0.42 %
Proposal 3 - Shareholders ratified the appointment of PricewaterhouseCoopers LLP as Registrant's independent registered public accounting firm for 2026.
ForAgainstAbstainBroker Non-Votes
2,119,761,224159,793,4714,867,982N/A
92.79 %7.00 %0.21 %
SHAREHOLDER PROPOSALS
Proposal 4 - Shareholders did not approve the proposal for a report on congruence of security, resiliency, and climate initiatives.
ForAgainstAbstainBroker Non-Votes
22,730,0441,879,975,35525,422,909356,294,369
1.18 %97.50 %1.32 %


2


Proposal 5 - Shareholders did not approve the proposal on independent board chairman.
ForAgainstAbstainBroker Non-Votes
677,058,9901,234,913,80016,155,518356,294,369
35.11 %64.05 %0.84 %
Proposal 6 - Shareholders did not approve the proposal on lobbying alignment.
ForAgainstAbstainBroker Non-Votes
254,439,9511,646,771,50826,916,849356,294,369
13.20 %85.41 %1.39 %
Proposal 7 - Shareholders did not approve the proposal on sustainability ROI report.
ForAgainstAbstainBroker Non-Votes
31,910,1971,868,643,97427,574,137356,294,369
1.65 %96.92 %1.43 %
Item 9.01 Financial Statements and Exhibits

(d)    Exhibit
Exhibit No.Description of Exhibit
101Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
JPMorgan Chase & Co.
(Registrant)


By:/s/ Reid R. Broda
Reid R. Broda
Corporate Secretary



Dated:May 21, 2026
3
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from JPMorgan Chase & Co (JPM)

Reference

Frequently asked questions

When did JPMorgan Chase & Co file this 8-K?
JPMorgan Chase & Co (JPM) filed this Current Report (Form 8-K) with the SEC on May 21, 2026. The accession number assigned by EDGAR is 0000019617-26-000228.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders reelected all 11 directors, approved executive compensation and PwC audit; rejected governance proposals. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find JPMorgan Chase & Co's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K JPMorgan Chase & Co has filed under CIK 19617, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer